Exact Mass: 327.2409

Exact Mass Matches: 327.2409

Found 57 metabolites which its exact mass value is equals to given mass value 327.2409, within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error 0.0002 dalton.

(9E)-9-nitrooctadecenoic Acid

(9E)-9-nitrooctadec-9-enoic acid

C18H33NO4 (327.2409)


(9E)-9-nitrooctadecenoic Acid, also known as (e)-9-Nitrooctadec-9-enoate, is classified as a member of the Long-chain fatty acids. Long-chain fatty acids are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. (9E)-9-nitrooctadecenoic Acid is considered to be practically insoluble (in water) and acidic. (9E)-9-nitrooctadecenoic Acid is a fatty acid lipid molecule

   

(9E)-10-nitrooctadecenoic Acid

(9E)-10-nitrooctadec-9-enoic acid

C18H33NO4 (327.2409)


(9E)-10-nitrooctadecenoic Acid, also known as 10-Nitroelaidic acid or (e)-10-Nitrooctadec-9-enoate, is classified as a member of the Long-chain fatty acids. Long-chain fatty acids are fatty acids with an aliphatic tail that contains between 13 and 21 carbon atoms. (9E)-10-nitrooctadecenoic Acid is considered to be practically insoluble (in water) and acidic. (9E)-10-nitrooctadecenoic Acid is a fatty acid lipid molecule

   

(6E)-Undec-6-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-6-enoyloxy)butanoate

C18H33NO4 (327.2409)


(6E)-Undec-6-enoylcarnitine is an acylcarnitine. More specifically, it is an (6E)-undec-6-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (6E)-Undec-6-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (6E)-Undec-6-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(2E)-Undec-2-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-2-enoyloxy)butanoate

C18H33NO4 (327.2409)


(2E)-Undec-2-enoylcarnitine is an acylcarnitine. More specifically, it is an (2E)-undec-2-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (2E)-Undec-2-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (2E)-Undec-2-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(5E)-Undec-5-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-5-enoyloxy)butanoate

C18H33NO4 (327.2409)


(5E)-Undec-5-enoylcarnitine is an acylcarnitine. More specifically, it is an (5E)-undec-5-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (5E)-Undec-5-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (5E)-Undec-5-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(4E)-Undec-4-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-4-enoyloxy)butanoate

C18H33NO4 (327.2409)


(4E)-Undec-4-enoylcarnitine is an acylcarnitine. More specifically, it is an (4E)-undec-4-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (4E)-Undec-4-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (4E)-Undec-4-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(7E)-Undec-7-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-7-enoyloxy)butanoate

C18H33NO4 (327.2409)


(7E)-Undec-7-enoylcarnitine is an acylcarnitine. More specifically, it is an (7E)-undec-7-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (7E)-Undec-7-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine (7E)-Undec-7-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undec-3-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-3-enoyloxy)butanoate

C18H33NO4 (327.2409)


Undec-3-enoylcarnitine is an acylcarnitine. More specifically, it is an undec-3-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undec-3-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undec-3-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undec-9-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-9-enoyloxy)butanoate

C18H33NO4 (327.2409)


Undec-9-enoylcarnitine is an acylcarnitine. More specifically, it is an undec-9-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undec-9-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undec-9-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Undec-8-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-8-enoyloxy)butanoate

C18H33NO4 (327.2409)


Undec-8-enoylcarnitine is an acylcarnitine. More specifically, it is an undec-8-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. Undec-8-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine Undec-8-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

undec-10-enoylcarnitine

4-(trimethylazaniumyl)-3-(undec-10-enoyloxy)butanoate

C18H33NO4 (327.2409)


undec-10-enoylcarnitine is an acylcarnitine. More specifically, it is an undec-10-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. undec-10-enoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine undec-10-enoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Nitrooleate

10-Nitro-9(e)-octadec-9-enoic acid

C18H33NO4 (327.2409)


   

Nitro-oleic acid

2-nitrooctadec-9-enoic acid

C18H33NO4 (327.2409)


   

18-Nitrooctadec-9-enoic acid

18-Nitrooctadec-9-enoic acid

C18H33NO4 (327.2409)


   

N-(3-Hydroxytetradecanoyl)-DL-homoserine lactone

N-(3-Hydroxytetradecanoyl)-DL-homoserine lactone

C18H33NO4 (327.2409)


   

3-hydroxy-C14 homoserine lactone

3-hydroxy-N-(2-oxooxolan-3-yl)tetradecanamide

C18H33NO4 (327.2409)


CONFIDENCE standard compound; INTERNAL_ID 218

   

9-Nitrooleate-d17

9-Nitrooleate-d17

C18H33NO4 (327.2409)


   

9-Nitrooleate

9-Nitrooleate

C18H33NO4 (327.2409)


   

10-Nitrooleate

10-Nitrooleate

C18H33NO4 (327.2409)


   

9-nitrooctadec-9E-enoic acid

9-nitrooctadec-9E-enoic acid

C18H33NO4 (327.2409)


   

10-nitro-9E-octadecenoic acid

10-nitro-9E-octadecenoic acid

C18H33NO4 (327.2409)


   

9-nitro-9E-octadecenoic acid

9-nitro-9E-octadecenoic acid

C18H33NO4 (327.2409)


   

NA 18:2;O3

N-(3-Hydroxy-9Z-hexadecenoyl) glycine

C18H33NO4 (327.2409)


   

N-Tetradecanoyl-4-hydroxy-L-proline

N-Tetradecanoyl-4-hydroxy-L-proline

C18H33NO4 (327.2409)


   

10-Nitrooleic acid

10-Nitrooleic acid

C18H33NO4 (327.2409)


D000893 - Anti-Inflammatory Agents

   

(E)-2-nitrooctadec-9-enoic acid

(E)-2-nitrooctadec-9-enoic acid

C18H33NO4 (327.2409)


D000893 - Anti-Inflammatory Agents

   

Undec-3-enoylcarnitine

Undec-3-enoylcarnitine

C18H33NO4 (327.2409)


   

Undec-9-enoylcarnitine

Undec-9-enoylcarnitine

C18H33NO4 (327.2409)


   

Undec-8-enoylcarnitine

Undec-8-enoylcarnitine

C18H33NO4 (327.2409)


   

(6E)-Undec-6-enoylcarnitine

(6E)-Undec-6-enoylcarnitine

C18H33NO4 (327.2409)


   

(2E)-Undec-2-enoylcarnitine

(2E)-Undec-2-enoylcarnitine

C18H33NO4 (327.2409)


   

(5E)-Undec-5-enoylcarnitine

(5E)-Undec-5-enoylcarnitine

C18H33NO4 (327.2409)


   

(4E)-Undec-4-enoylcarnitine

(4E)-Undec-4-enoylcarnitine

C18H33NO4 (327.2409)


   

(7E)-Undec-7-enoylcarnitine

(7E)-Undec-7-enoylcarnitine

C18H33NO4 (327.2409)


   

18-Nitrooctadec-9-enoic acid

18-Nitrooctadec-9-enoic acid

C18H33NO4 (327.2409)


   

(E)-3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]tetradec-5-enoate

(E)-3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]tetradec-5-enoate

C18H33NO4 (327.2409)


   

(9E)-10-nitrooctadecenoic Acid

(9E)-10-nitrooctadecenoic Acid

C18H33NO4 (327.2409)


A nitro fatty acid that is (9E)-octadec-9-enoic (elaidic) acid substituted by a nitro group at position 10.

   

3-hydroxy-N-(2-oxooxolan-3-yl)tetradecanamide

3-hydroxy-N-(2-oxooxolan-3-yl)tetradecanamide

C18H33NO4 (327.2409)


   

O-undecenoylcarnitine

O-undecenoylcarnitine

C18H33NO4 (327.2409)


An O-acylcarnitine in which the acyl group is specified as undecenoyl (position of double bond not specified).

   

O-(dimethylnonenoyl)carnitine

O-(dimethylnonenoyl)carnitine

C18H33NO4 (327.2409)


An O-acylcarnitine in which the acyl group is specified as dimethylnonenoyl (positions of double bond and methyl groups not specified).

   

(9E)-9-nitrooctadecenoic Acid

(9E)-9-nitrooctadecenoic Acid

C18H33NO4 (327.2409)


A nitro fatty acid that is (9E)-octadec-9-enoic (elaidic) acid substituted by a nitro group at position 9.

   

AcCa(11:1)

Acetyl-CoA carboxylase-alpha(11:1)

C18H33NO4 (327.2409)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

9-Nitrooleic acid

9-Nitrooleic acid

C18H33NO4 (327.2409)


   

Nitrooleic acid

Nitrooleic acid

C18H33NO4 (327.2409)


   

NA-Ser 15:1(9Z)

NA-Ser 15:1(9Z)

C18H33NO4 (327.2409)


   

NA-Thr 14:1(9Z)

NA-Thr 14:1(9Z)

C18H33NO4 (327.2409)


   
   

undecenoylcarnitine

3-hydroxy-4-oxo-3-[(trimethylazaniumyl)methyl]tetradec-5-enoate

C18H33NO4 (327.2409)


new metabolite created

   

4-(5-ethyl-3-methyloxolan-2-yl)-4-hydroxy-n-(1-hydroxy-3-methylpentan-2-yl)pent-2-enimidic acid

4-(5-ethyl-3-methyloxolan-2-yl)-4-hydroxy-n-(1-hydroxy-3-methylpentan-2-yl)pent-2-enimidic acid

C18H33NO4 (327.2409)


   

n-(1-hydroxy-3-methylpentan-2-yl)-3-[3-(4-hydroxyhexan-2-yl)-2-methyloxiran-2-yl]prop-2-enimidic acid

n-(1-hydroxy-3-methylpentan-2-yl)-3-[3-(4-hydroxyhexan-2-yl)-2-methyloxiran-2-yl]prop-2-enimidic acid

C18H33NO4 (327.2409)


   

(2e)-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-3-[(2r)-3-[(2s,4r)-4-hydroxyhexan-2-yl]-2-methyloxiran-2-yl]prop-2-enimidic acid

(2e)-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-3-[(2r)-3-[(2s,4r)-4-hydroxyhexan-2-yl]-2-methyloxiran-2-yl]prop-2-enimidic acid

C18H33NO4 (327.2409)


   

(2e)-4-[(2r,3s,5r)-5-ethyl-3-methyloxolan-2-yl]-4-hydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]pent-2-enimidic acid

(2e)-4-[(2r,3s,5r)-5-ethyl-3-methyloxolan-2-yl]-4-hydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]pent-2-enimidic acid

C18H33NO4 (327.2409)


   

(4s)-4-[(2r,3s,5r)-5-ethyl-3-methyloxolan-2-yl]-4-hydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]pent-2-enimidic acid

(4s)-4-[(2r,3s,5r)-5-ethyl-3-methyloxolan-2-yl]-4-hydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]pent-2-enimidic acid

C18H33NO4 (327.2409)


   

(2e,4s)-4-[(2r,3s,5r)-5-ethyl-3-methyloxolan-2-yl]-4-hydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]pent-2-enimidic acid

(2e,4s)-4-[(2r,3s,5r)-5-ethyl-3-methyloxolan-2-yl]-4-hydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]pent-2-enimidic acid

C18H33NO4 (327.2409)


   

(2e)-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-3-[(2r,3s)-3-[(2s,4r)-4-hydroxyhexan-2-yl]-2-methyloxiran-2-yl]prop-2-enimidic acid

(2e)-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-3-[(2r,3s)-3-[(2s,4r)-4-hydroxyhexan-2-yl]-2-methyloxiran-2-yl]prop-2-enimidic acid

C18H33NO4 (327.2409)


   

n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-3-[(2r,3s)-3-[(2s,4r)-4-hydroxyhexan-2-yl]-2-methyloxiran-2-yl]prop-2-enimidic acid

n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-3-[(2r,3s)-3-[(2s,4r)-4-hydroxyhexan-2-yl]-2-methyloxiran-2-yl]prop-2-enimidic acid

C18H33NO4 (327.2409)